Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

GBM

  • Open Access
    Enzalutamide Enhanced Honokiol-induced Apoptotic Insults to Drug-resistant Glioblastoma Cells via an Intrinsic Bak-mitochondrion-caspase Cascade Mechanism
    CHENG-YEN CHEN, JUI-TAI CHEN, SHING-HWA LIU, EDWIN CHEN and RUEI-MING CHEN
    Anticancer Research June 2026, 46 (6) 3117-3130; DOI: https://doi.org/10.21873/anticanres.18185
  • You have access
    Synergistic Effects of Honokiol on Camptothecin-triggered Apoptosis of Drug-resistant Glioblastoma Cells via CDK1-mediated G2/M Arrest and Intrinsic ROS-Mitochondrion-dependent Pathway
    CHIH-PIN YANG, JUI-TAI CHEN, SHING-HWA LIU, EDWIN CHEN and RUEI-MING CHEN
    Anticancer Research February 2026, 46 (2) 633-649; DOI: https://doi.org/10.21873/anticanres.17975
  • You have access
    YTHDF3 Modulates EGFR/ATK/ERK/p21 Signaling Axis to Promote Cancer Progression and Osimertinib Resistance of Glioblastoma Cells
    HSUN-HUA LEE, CHING-CHUAN HSIEH, CHENG-CHIH CHANG, WAN-TING LIAO and HSIANG-CHENG CHI
    Anticancer Research December 2023, 43 (12) 5485-5498; DOI: https://doi.org/10.21873/anticanres.16751
  • You have access
    Anticancer Non-narcotic Opium Alkaloid Papaverine Suppresses Human Glioblastoma Cell Growth
    MANA INADA, AKIRA SATO, MIKA SHINDO, YOHEI YAMAMOTO, YASUHARU AKASAKI, KOICHI ICHIMURA and SEI-ICHI TANUMA
    Anticancer Research December 2019, 39 (12) 6743-6750; DOI: https://doi.org/10.21873/anticanres.13889
  • You have access
    Immune Phenotype Correlates With Survival in Patients With GBM Treated With Standard Temozolomide-based Therapy and Immunotherapy
    MARKOS ANTONOPOULOS, STEFAAN W. VAN GOOL, DIMITRA DIONYSIOU, NORBERT GRAF and GEORGIOS STAMATAKOS
    Anticancer Research April 2019, 39 (4) 2043-2051; DOI: https://doi.org/10.21873/anticanres.13315
  • You have access
    Interventions to Reduce Neurological Symptoms in Patients with GBM Receiving Radiotherapy: From Theory to Clinical Practice
    LUCIA PALOMBI, PAOLO MARCHETTI, MAURIZIO SALVATI, MATTIA FALCHETTO OSTI, LUIGI FRATI and ALESSANDRO FRATI
    Anticancer Research April 2018, 38 (4) 2423-2427;
  • You have access
    Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme
    JIRI POLIVKA, JIRI POLIVKA, LUBOS HOLUBEC, TEREZA KUBIKOVA, VLADIMIR PRIBAN, ONDREJ HES, KRISTYNA PIVOVARCIKOVA and INKA TRESKOVA
    Anticancer Research January 2017, 37 (1) 21-33;
  • You have access
    Radio-chemotherapy with Temozolomide in Elderly Patients with Glioblastoma. A Mono-institutional Experience
    FRANCESCO PASQUALETTI, PATRIZIA FERRAZZA, PAOLA COCUZZA, LUCIA FATIGANTE, GIUSEPPE PASQUALETTI, MARIA GRAZIA FABBRINI and FABIO MONZANI
    Anticancer Research August 2014, 34 (8) 4281-4285;
  • You have access
    Long-term Outcome in Patients with Recurrent Malignant Glioma Treated with Perillyl Alcohol Inhalation
    CLOVIS O. DA FONSECA, RAPHAEL M. TEIXEIRA, JÚLIO CESAR T. SILVA, JULIANA DE SALDANHA DA GAMA FISCHER, OSÓRIO C. MEIRELLES, JOSE ALBERTO LANDEIRO and THEREZA QUIRICO-SANTOS
    Anticancer Research December 2013, 33 (12) 5625-5631;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire